查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1831840

2025 年至 2033 年生物外科市場報告（按產品、來源、應用、最終用戶和地區）

Biosurgery Market Report by Product, Source, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球生物外科市場規模達148億美元。展望未來， IMARC Group預計到2033年，市場規模將達到251億美元，2025-2033年期間的複合年成長率（CAGR）為5.76%。北美是生物外科最大的區域市場，這得益於其先進的醫療基礎設施、對研發活動的大量投入，以及推動創新和擴張的領導者。此外，外科手術的增加、醫療器械技術的進步以及對複雜手術中有效傷口管理的需求不斷成長，正在改善全球患者的手術效果並縮短患者的康復時間。

隨著醫療技術的進步和醫療保健需求的不斷變化，生物外科市場正在發生巨大的變化。生物外科技術日益成長的前景和複雜性，正在促進醫療部門和學術中心之間的更多互動。學術機構和研究機構在研究新的生物材料、創造新的手術方法以及透過臨床試驗測試新產品的有效性方面佔據著中心地位。這種合作環境正在推動創新生物外科解決方案的快速發展，因為製造商和科學家正在合作更快地將新產品推向市場。此外，學術中心在培訓未來的外科醫生了解生物外科的優勢和應用方面發揮著積極作用。隨著越來越多的醫療保健專業人員接受生物衍生產品處理的培訓，這些產品在臨床實務中的應用和接受度也不斷提高。合作研究也正在加深對複雜生物機制的理解，並將有用的見解應用於開發改進的生物外科解決方案，使不同的患者群體受益。

生物外科市場趨勢：

生物外科產品的技術進步

技術發展對生物外科市場的快速成長貢獻巨大。生物材料的持續改進正在提高止血鉗、黏合劑和組織工程產品等產品的效率。各公司正瞄準更有效率、生物相容性和永續性的外科產品。例如，促進傷口更快癒合和增強組織再生的生物活性材料的進步正在徹底改變這一領域。此外，3D列印技術的發展促進了個人化植入物和手術器械的生產，為更有效率、更客製化的外科干預鋪平了道路。這些發展不僅提高了手術效果，也使生物外科產品更容易取得且價格更實惠。隨著新技術的出現，生物外科解決方案的範圍正在擴大，能夠滿足更多類型的手術需求，並促進改善各醫學專業的病患照護。 3D Systems宣布，與瑞士巴塞爾大學醫院合作，利用其獨家的即時醫療積層製造解決方案，打造全球首款符合醫療器材法規 (MDR) 的3D列印PEEK臉部植入物。 Florian Thieringer教授和Neha Sharma博士及其生物醫學工程師團隊，利用3D Systems的技術和製造知識，高效地創建並生產了一款客製化設備，以滿足患者的特定需求。該植入物於2025年3月18日在醫院成功完成手術。

微創手術需求增加

對微創手術日益成長的需求是市場成長的根本動力之一。由於醫護人員和患者都希望最大限度地縮短傳統開放性手術的恢復時間和風險，越來越多的微創手術被採用。在大多數情況下，這些手術切口更小，對周圍組織的創傷更小，失血量更少，從而縮短了恢復期並減少了併發症。包括止血鉗和生物黏合劑在內的生物外科器械是這些手術的一部分，因為它們有助於更好地閉合組織並精確控制出血。外科醫師也會在微創手術中使用生物材料來促進傷口癒合並預防感染。隨著各專業領域微創手術的趨勢日益明顯，對支持這些手術的生物外科解決方案的需求也不斷成長，這進一步推動了市場的成長。 IMARCIMARC Group預測，到2033年，全球微創手術市場規模預計將達到949億美元。

全球人口老化

全球人口老化在推動生物外科市場發展方面發揮巨大作用。根據世界衛生組織 (WHO) 在 2025 年發表的一篇文章，預計到 2030 年，60 歲及以上人口數量將增至 14 億。隨著年齡的成長，人們往往會患上各種需要手術的疾病，包括關節置換、心血管手術和骨科手術。老年患者的恢復機制通常較慢，更容易出現手術和術後併發症。組織工程移植物、傷口癒合產品和生物黏合劑等生物外科設備正在解決這些問題，這些設備有助於加快患者恢復速度，最大限度地降低感染風險，並最佳化組織再生。其次，由於老年患者患有更多需要持續醫療照護的慢性疾病，對複雜的生物外科解決方案的需求也不斷增加。因此，全球老年人口正在推動市場成長，因為醫療保健系統擴大採用先進技術來改善手術效果並縮短老年患者的恢復期。

生物外科市場成長動力：

醫療成本不斷增加，對先進外科手術解決方案的敏感度也不斷提高

全球醫療保健支出不斷成長，生物外科產品等先進外科解決方案的優勢日益凸顯。如今，醫護人員和患者都更加意識到生物工程外科產品相較於傳統合成產品的優勢，例如更短的癒合時間、更少的併發症以及更好的生物相容性，這些對於最大程度地提高手術效果至關重要。醫療保健系統，尤其是已開發國家的醫療保健系統，目前正在大力投資此類先進的解決方案，以提高護理品質並控制長期康復和併發症的成本。隨著越來越多的醫學專家採用先進的外科手術方法，生物活性敷料、組織移植物和可生物分解縫線等生物外科器械正成為各種手術的重要組成部分。

慢性病和外科手術發生率不斷上升

糖尿病、心血管疾病和肥胖等慢性疾病的發生率不斷上升，推動著市場的成長。大多數慢性疾病都可能導致需要手術治療的疾病，例如糖尿病潰瘍、血管外科手術和關節置換。隨著這些疾病的日益普遍，對能夠加快康復速度並減少併發症的新型外科產品的需求也日益成長。生物外科產品，例如用於傷口護理的生物解決方案、組織修復解決方案和止血劑，在外科手術中的應用日益廣泛，旨在改善慢性患者的治療效果。例如，生物移植物和敷料在糖尿病患者難以癒合的慢性複雜傷口的癒合過程中發揮著至關重要的作用。隨著全球慢性病負擔的日益加重，對生物外科產品的需求也日益成長，使得這些產品成為當代外科手術不可或缺的一部分。

擴大新興市場的醫療保健覆蓋率

新興經濟體醫療保健服務可近性的提升正在推動市場成長。發展中國家醫療基礎設施的改善和先進醫療技術的普及，持續刺激對生物外科產品的需求。這些國家在骨科、心血管和創傷護理領域的手術率不斷上升，這推動了生物外科產品的使用。隨著民眾獲得優質醫療服務的管道日益暢通，能夠改善手術效果的生物外科產品的應用也日益廣泛。此外，許多政府和醫療體係正在投資旨在提升外科護理水平、最大程度降低醫療併發症發生率的項目，從而進一步推動了對生物外科解決方案的需求。

生物外科市場細分：

按產品分類：

  • 骨移植替代品
  • 軟組織附著
  • 止血劑
  • 外科密封劑和黏合劑
  • 防沾黏屏障
  • 釘合線加固

骨移植替代品佔大部分市場佔有率

骨移植替代品是骨移植的重要替代方案。這些替代品在許多外科手術中發揮關鍵作用，支持骨科、創傷、脊椎外科和牙科應用中的骨再生和修復。它們旨在透過促進骨骼發育並取代需要從患者自身取骨的傳統自體移植，最大限度地降低供體部位發病率和感染風險。此外，骨骼和關節問題的日益增加、對微創手術的需求以及生物材料技術的發展也推動了骨移植替代品的擴張。新型合成和複合移植材料的研發也推動了這個細分市場的成長，這些材料的研發具有更佳的骨傳導和骨誘導特性。例如，2023年5月23日，專注於利用先進的細胞和自體技術改善手術效果的Royal Biologics, Inc.推出了BIO-REIGN 3D。這款創新骨移植替代品首次使用了天然高交聯碳水化合物聚合物。它旨在增強骨移植程序，這項專有技術與 Royal Biologics 對 Molecular Matrix 的專利 Osteo-P BGS 技術的授權協議一起推出。

依來源分類：

  • 天然/生物製品
  • 合成產品

天然/生物製劑產品佔據產業最大佔有率

根據生物外科市場概況，天然/生物製劑因其有效的癒合特性和生物相容性佔據了最大的市場佔有率。這些產品源自於人體天然存在的物質或其他生物來源，包括纖維蛋白封閉劑、膠原基質和殼聚醣溶液。此外，天然/生物製劑能夠模擬自然生理過程，顯著降低排斥反應和不良反應的風險，使其成為外科手術的首選。此外，生物技術的進步提高了這些材料的安全性和有效性，進一步鞏固了其市場主導地位。因此，微創手術需求的不斷成長，加上需要複雜手術的慢性疾病的日益增多，持續推動天然/生物製劑在市場上的成長。

按應用分類：

  • 骨科手術
  • 一般外科
  • 神經外科
  • 心血管外科
  • 婦科手術
  • 其他

神經外科代表著領先的細分市場

神經外科手術複雜且精準度要求極高。此外，生物外科產品（如密封劑、止血劑和防沾黏膜）廣泛應用於神經外科手術，用於控制出血、封閉組織並減少術後併發症。此外，腦腫瘤、癲癇和帕金森氏症等神經系統疾病的發生率不斷上升，加上神經外科技術的進步，也推動了該領域的需求。此外，微創手術的廣泛應用需要高效的生物外科解決方案來改善患者預後，這進一步推動了生物外科市場的成長。生物外科產品的技術創新也推動了這一趨勢，旨在改善手術效果並縮短恢復時間。

按最終用戶分類：

  • 醫院
  • 診所
  • 其他

醫院在市場上佔據明顯主導地位

醫院提供各種各樣的外科手術，這些手術經常使用生物外科產品。這些產品包括止血劑、外科密封劑和黏合劑，對於控制術中和術後出血以及促進組織癒合至關重要。此外，醫院處理大量患者和進行複雜手術的能力也增加了對生物外科的需求。此外，外科技術的不斷進步和對微創手術日益成長的偏好進一步擴大了生物外科解決方案在醫院環境中的應用。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大的生物外科市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是生物外科最大的區域市場。

北美憑藉其先進的醫療基礎設施、對研發活動的大量投入以及推動創新和擴張的領先企業，成為生物外科市場的領先地區。此外，北美慢性病發病率的上升和老齡化人口的成長也推動了對生物外科產品的需求。根據生物外科市場預測，這些因素，加上有利的政府政策和強勁的微創手術趨勢，將繼續鞏固北美在全球生物外科市場的領先地位。

本報告回答的關鍵問題：

  • 全球生物外科市場迄今表現如何，未來幾年將如何表現？
  • 全球生物外科市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球生物外科市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的生物外科市場？
  • 根據產品，市場是如何分類的？
  • 生物外科市場上最有吸引力的產品是什麼？
  • 根據來源，市場詳細情形如何？
  • 生物外科市場中最具吸引力的來源是什麼？
  • 根據應用，市場是如何分類的？
  • 生物外科市場中最具吸引力的應用是什麼？
  • 根據最終用戶，市場是如何分類的？
  • 生物外科市場中最具吸引力的最終用戶是誰？
  • 市場的競爭結構是怎麼樣的？
  • 全球生物外科市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 全球生物外科市場迄今表現如何，未來幾年將如何表現？
  • 全球生物外科市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球生物外科市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的生物外科市場？
  • 根據產品，市場是如何分類的？
  • 生物外科市場上最有吸引力的產品是什麼？
  • 根據來源，市場詳細情形如何？
  • 生物外科市場中最具吸引力的來源是什麼？
  • 根據應用，市場是如何分類的？
  • 生物外科市場中最具吸引力的應用是什麼？
  • 根據最終用戶，市場是如何分類的？
  • 生物外科市場中最具吸引力的最終用戶是誰？
  • 市場的競爭結構是怎麼樣的？
  • 全球生物外科市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球生物外科市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 骨移植替代品
  • 軟組織附著
  • 止血劑
  • 外科密封劑和黏合劑
  • 防沾黏屏障
  • 釘合線加固

第7章：市場區隔：依來源

  • 天然/生物製品
  • 合成產品

第 8 章：市場區隔：按應用

  • 骨科手術
  • 一般外科
  • 神經外科
  • 心血管外科
  • 婦科手術
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院
  • 診所
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • CryoLife Inc.
    • CSL Limited
    • Hemostasis LLC
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Sanofi SA
    • Smith & Nephew plc
    • Stryker Corporation
    • Surgalign Spine Technologies Inc.
Product Code: SR112025A4522

The global biosurgery market size reached USD 14.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.76% during 2025-2033. North America was the largest regional market for biosurgery owing to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Moreover, the increasing surgical procedures, technological advancements in medical devices, and growing demand for effective wound management in complex surgeries is enhancing surgical outcomes and recovery times for patients across the globe.

The market for biosurgery is undergoing immense changes with the advancement of medical technologies and evolving healthcare requirements. The growing promise and complexity of biosurgical technologies are stimulating more interaction between the medical sector and academic centers. Academic institutions and research institutes are taking center stage in investigating new biologic materials, creating new surgical methods, and testing the efficacy of new products through clinical trials. This cooperative setting is developing the swift growth of innovative biosurgical solutions, as manufacturers and scientists collaborate to advance new products to market more quickly. In addition, academic centers play an active role in training future surgeons about the advantages and applications of biosurgery. With increasing numbers of healthcare professionals being trained in the handling of biologically derived products, the uptake and acceptance of these products in clinical practice is also growing. Collaborative research endeavors are also refining the understanding of complicated biological mechanisms, and useful insights are being utilized in developing improved biosurgical solutions that can benefit various patient groups.

Biosurgery Market Trends:

Technological Progress in Biosurgical Products

Technological developments are contributing tremendously to the faster growth of the biosurgery market. Ongoing improvements in biologic materials are increasing the efficiency of products like hemostats, adhesives, and tissue-engineered products. Companies are targeting more efficient, biocompatible, and sustainable surgical products. For instance, advances in bioactive materials that promote faster wound healing and enhance tissue regeneration are revolutionizing the space. In addition, development in 3D printing technology is facilitating the production of personalized implants and surgical instruments, making way for more efficient and tailor-made surgical interventions. These developments not only enhance surgical performance but also make biosurgical products more accessible and affordable. With new technologies coming onto the scene, the scope of biosurgical solutions is increasing, treating more types of surgical requirements and facilitating improved patient care across a variety of medical specialties. 3D Systems revealed that, in partnership with University Hospital Basel (Switzerland), the Company's exclusive point-of-care additive manufacturing solution is utilized to create the world's first 3D-printed PEEK facial implant compliant with Medical Device Regulation (MDR). Prof. Florian Thieringer and Dr. Neha Sharma, along with their team of biomedical engineers, effectively created and produced a tailored device to meet a patient's specific requirement utilizing 3D Systems technology and manufacturing knowledge. This implant was utilized in a successful operation finished at the hospital on March 18, 2025.

Increased Demand for Minimally Invasive Procedures

The heightened need for minimally invasive procedures is one of the fundamental growth drivers in the market. As medical practitioners and patients aim to minimize the recovery time and risks involved with conventional open surgeries, more minimally invasive procedures are being performed. These surgeries, in most cases, entail smaller cuts, less trauma to the tissues around them, and less blood loss, resulting in shorter recovery periods and fewer complications. Biosurgical items, including hemostats and biologic adhesives, are part of these procedures as they facilitate better tissue sealing and bleeding control with accuracy. Surgeons are also employing biologic materials for better wound healing and the prevention of chances of infection in minimally invasive procedures. With the trend toward minimally invasive procedures in all specialties, the need for biosurgical solutions that enable these procedures is increasing, further fueling the market growth. IMARC Group predicts that the global minimally invasive surgery market is anticipated to reach USD 94.9 Billion by 2033.

Aging Global Population

The aging world population is playing a huge role in driving the biosurgery market. As per an article published by the World Health Organization (WHO) in 2025, the number of people aged 60 and above is anticipated to increase to 1.4 billion by 2030. As individuals grow older, they tend to develop a variety of ailments that call for surgeries, including joint replacements, cardiovascular procedures, and orthopedic procedures. Elderly patients generally possess slower recovery mechanisms and are more prone to surgical and post-surgical complications. These issues are being dealt with by biosurgical devices like tissue-engineered grafts, wound healing products, and biologic adhesives that are facilitating quicker recovery, minimizing the risk of infection, and optimizing tissue regeneration. Second, as older patients have more chronic diseases that necessitate continuous medical care, the need for sophisticated biosurgical solutions is also on the increase. The elderly population worldwide is therefore fueling the market growth since healthcare systems are increasingly embracing advanced technologies to enhance surgical outcomes and reduce recovery periods for older patients.

Biosurgery Market Growth Drivers:

Increasing Healthcare Costs and Sensitivity to Advanced Surgical Solutions

Health care spending is rising globally, and advanced surgical solutions, such as biosurgical products, are increasingly recognized as having advantages. Both healthcare professionals and patients are more aware today about the benefits that biologically engineered surgical products provide over conventional synthetic ones. These include lower healing times, fewer complications, and better biocompatibility, which are important for maximizing surgical outcomes. Healthcare systems, especially those in the developed world, are now investing heavily in such sophisticated solutions to enhance care quality and contain the costs of long-term recovery and complications. With more medical specialists adopting sophisticated surgical methods, biosurgical devices like bioactive dressings, tissue grafts, and biodegradable sutures are becoming part and parcel of a variety of procedures.

Increasing Incidence of Chronic Diseases and Surgical Surgeries

The increasing incidence of chronic diseases, including diabetes, cardiovascular disease, and obesity, is propelling the market growth. Most chronic diseases result in conditions that are likely to be treated with surgery, like diabetic ulcers, vascular surgeries, and joint replacements. As these conditions become more prevalent, the demand for novel surgical products that enhance faster recovery and lower complications is increasing. Biosurgical products like biologic solutions for wound care, tissue repair solutions, and hemostatics are finding growing use in surgeries to provide improved patient outcomes for chronic patients. For instance, biologic grafts and dressings play a crucial role in healing chronic, complicated wounds that are slow to heal in diabetic patients. With the growing global burden of chronic disease, the need for biosurgical products is spreading wide, making these products integral parts of contemporary surgical procedures.

Expanding Healthcare Access in Emerging Markets

Increased access to healthcare in emerging economies is bolstering the market growth. The developing world's improvement in healthcare infrastructure and access to sophisticated medical technology continues to catalyze the demand for biosurgical products. These nations are observing increased rates of surgeries in orthopedic, cardiovascular, and trauma care segments, which are driving the use of biosurgery products. As the populations become increasingly accessible to quality healthcare, biosurgical products with improved surgical outcomes are finding increased applications. Furthermore, numerous governments and healthcare systems are investing in projects aimed at enhancing surgical care and minimizing the incidence of medical complications, thus creating additional demand for biologically derived surgical solutions.

Biosurgery Market Segmentation:

Breakup by Product:

  • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement

Bone-graft substitutes account for the majority of the market share

Bone-graft substitutes are crucial alternatives to bone grafting. These stand-ins play a critical role in many surgical operations, supporting bone regeneration and repair in orthopedics, trauma, spine surgery, and dentistry applications. They are intended to minimize the risk of donor site morbidity and infection by promoting bone development and replacing conventional autografts, which require removing bone from the patient's own body. Furthermore, the expansion is driven by the increasing frequency of bone and joint problems, the need for less intrusive operations, and developments in biomaterial technology. The growth of this market segment is also fueled by the creation of novel synthetic and composite grafts with improved osteoconductive and osteoinductive qualities. For instance, on 23 May 2023, Royal Biologics, Inc., a company focused on advanced cellular and autologous technologies for improved surgical outcomes, unveiled BIO-REIGN 3D. This innovative bone graft substitute is the first to use a natural hyper-crosslinked carbohydrate polymer. It is designed to enhance bone grafting procedures, and this proprietary technology is introduced alongside Royal Biologics' licensing agreement for Molecular Matrix's patented Osteo-P BGS technology.

Breakup by Source:

  • Natural/Biologics Products
  • Synthetic Products

Natural/biologics products hold the largest share of the industry

According to the biosurgery market overview, natural/biologics represent the largest segment due to their effective healing properties and biocompatibility. These products, derived from substances that are naturally present in the human body or other biological sources, include fibrin sealants, collagen-based matrices, and chitosan-based solutions. Additionally, natural/biologics product's ability to mimic natural physiological processes significantly reduces the risk of rejection and adverse reactions, making them highly preferred in surgical procedures. Moreover, market dominance is further supported by advancements in biotechnology that enhance the safety and efficacy of these materials. Consequently, the increasing demand for minimally invasive surgeries, coupled with the growing prevalence of chronic diseases requiring complex surgeries, continues to drive the growth of natural/biologics products in the market.

Breakup by Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Others

Neurological surgery represents the leading market segment

Neurological surgeries are complex and require critical precision. Additionally, biosurgery products, such as sealants, hemostatic agents, and adhesion barriers, are extensively used in neurological procedures to manage bleeding, seal tissues, and reduce post-operative complications. Moreover, the rising prevalence of neurological disorders, such as brain tumors, epilepsy, and Parkinson's disease, coupled with advancements in neurosurgical techniques are escalating the demand in this segment. Besides, the widespread adoption of minimally invasive (MI) surgeries, which require highly effective biosurgical solutions to enhance patient outcomes is further driving the biosurgery market growth. This trend is supported by technological innovations in biosurgery products, aimed at improving surgical outcomes and reducing recovery times.

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Hospital exhibits a clear dominance in the market

Hospitals offer a wide array of surgical procedures that frequently utilize biosurgical products. These products, which include hemostatic agents, surgical sealants, and adhesives, are integral in managing intraoperative and postoperative bleeding and promoting tissue healing. Additionally, hospitals' capacity to handle high patient volumes and conduct complex surgeries increases biosurgery demand. Additionally, the constant advancements in surgical techniques and the increasing preference for minimally invasive surgeries further amplify the utilization of biosurgical solutions in hospital settings.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biosurgery market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for biosurgery.

North America is the leading region due to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Additionally, the increasing prevalence of chronic diseases and the growing elderly population in North America contribute to a higher demand for biosurgical products. According to the biosurgery market forecast, these factors, combined with favorable government policies and a strong trend toward minimally invasive surgeries, will continue to strengthen North America's leading position in the global biosurgery market.

Competitive Landscape:

  • The biosurgery market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.
  • At present, biosurgery market players are actively enhancing market growth through a combination of strategic collaborations, innovative product launches, and expansions into new geographical markets. These companies invest heavily in research and development (R&D) to introduce advanced products that meet the increasing demands of minimally invasive surgeries and improved wound care. Additionally, market players are focusing on obtaining regulatory approvals across different regions, which helps in expanding their global footprint and accessing new markets. These strategies collectively contribute to the robust growth and resilience of the biosurgery market. For instance, in 2023, AROA Biosurgery Ltd. revealed the release of a new retrospective pilot case series that explores the use of Myriad Matrix and Myriad Morcells in the surgical treatment of contaminated volumetric soft tissue defects. It reviewed 13 complex traumatic wounds in 10 patients at a single facility. The study reported an average time of 23.4+-9.2 days for achieving soft tissue coverage and fill, with a median of one product application and no complications among participants. Moreover, the research focused on injuries from motor vehicle accidents, abdominal dehiscence after hernia repair, Fournier's Gangrene, compartment syndrome, and pressure injuries at a US Level 1 trauma center. It found that the Myriad products facilitated effective soft tissue formation with no reported complications, reinforcing the utility of AROA ECM products in trauma care.

Key Questions Answered in This Report:

  • How has the global biosurgery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biosurgery market?
  • What is the impact of each driver, restraint, and opportunity on the global biosurgery market?
  • What are the key regional markets?
  • Which countries represent the most attractive biosurgery market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biosurgery market?
  • What is the breakup of the market based on the source?
  • Which is the most attractive source in the biosurgery market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biosurgery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biosurgery market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biosurgery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosurgery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone-Graft Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Soft-Tissue Attachments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hemostatic Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Sealants and Adhesives
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Barriers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Staple Line Reinforcement
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Natural/Biologics Products
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 General Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurological Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gynecological Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Baxter International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CryoLife Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 CSL Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Hemostasis LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Integra Lifesciences Holdings Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Smith & Nephew plc
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Stryker Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Surgalign Spine Technologies Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Biosurgery Market: Major Drivers and Challenges
  • Figure 2: Global: Biosurgery Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Biosurgery Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Biosurgery Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Biosurgery Market: Breakup by Source (in %), 2024
  • Figure 6: Global: Biosurgery Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Biosurgery Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Biosurgery Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Biosurgery (Bone-Graft Substitutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Biosurgery (Bone-Graft Substitutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Biosurgery (Soft-Tissue Attachments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Biosurgery (Soft-Tissue Attachments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Biosurgery (Hemostatic Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Biosurgery (Hemostatic Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Biosurgery (Surgical Sealants and Adhesives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Biosurgery (Surgical Sealants and Adhesives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Biosurgery (Adhesion Barriers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Biosurgery (Adhesion Barriers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Biosurgery (Staple Line Reinforcement) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Biosurgery (Staple Line Reinforcement) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Biosurgery (Natural/Biologics Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Biosurgery (Natural/Biologics Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Biosurgery (Synthetic Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Biosurgery (Synthetic Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Biosurgery (Orthopedic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Biosurgery (Orthopedic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Biosurgery (General Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Biosurgery (General Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Biosurgery (Neurological Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Biosurgery (Neurological Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Biosurgery (Cardiovascular Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Biosurgery (Cardiovascular Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Biosurgery (Gynecological Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Biosurgery (Gynecological Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Biosurgery (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Biosurgery (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Biosurgery (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Biosurgery (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Biosurgery (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Biosurgery (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Biosurgery (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Biosurgery (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia-Pacific: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia-Pacific: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Biosurgery Market: Breakup by Country (in %), 2024
  • Figure 91: Middle East and Africa: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Global: Biosurgery Industry: SWOT Analysis
  • Figure 93: Global: Biosurgery Industry: Value Chain Analysis
  • Figure 94: Global: Biosurgery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosurgery Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Biosurgery Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Biosurgery Market Forecast: Breakup by Source (in Million USD), 2025-2033
  • Table 4: Global: Biosurgery Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Biosurgery Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Biosurgery Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Biosurgery Market: Competitive Structure
  • Table 8: Global: Biosurgery Market: Key Players